Magnesium Sulphate Injection in Treatment of Myofascial Trigger Points

• Status: Recruiting
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, single- center, randomized (1:1) clinical trial comparing the effectiveness of magnesium sulphate injections in treatment of myofascial trigger points in the masseter muscle versus the saline injection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fayoum University
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Definite diagnosis of myofascial pain with a referral, based on the DC/TMD criteria

• the presence of one or more trigger points in the unilateral or bilateral masseter muscle

• no history of any invasive procedures in the related masseter muscle.

Exclusion Criteria:

• Factors that can cause pain in the orofacial region other than MTPs (decayed tooth, TMJ internal disorder).

• Any systemic disease that possibly affects the masticatory system such as rheumatoid arthritis and epilepsy

• pregnancy and lactation.